Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cell Cycle (Georgetown, Tex.)|February 26, 2011
How phosphorylation controls p53Nicola J MacLaine, Ted R Hupp
Cancer Research|November 9, 2010
Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatinLynnette Marcar, Nicola J Maclaine, Ted R Hupp, et al.
The Journal of Biological Chemistry|September 18, 2009
CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stabilityAnne-Sophie Huart, Nicola J MacLaine, David W Meek, et al.
Molecular Cancer Research : MCR|February 1, 2008
Sensitivity of normal, paramalignant, and malignant human urothelial cells to inhibitors of the epidermal growth factor receptor signaling pathwayNicola J MacLaine, Michelle D Wood, Julie C Holder, et al.
European Urology|March 1, 2011
Immortalisation of normal human urothelial cells compromises differentiation capacityNikolaos T Georgopoulos, Lisa A Kirkwood, Claire L Varley, et al.
The Journal of Biological Chemistry|August 2, 2008
A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infectionNicola J MacLaine, Bodil Oster, Bettina Bundgaard, et al.
Journal of Immunological Methods|February 25, 2012
Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft modelsTerry A Gray, Nicola J MacLaine, Caroline O Michie, et al.
Pageof 1